138 related articles for article (PubMed ID: 9869614)
1. Chronic blockade of endothelin receptors in cirrhotic rats: hepatic and hemodynamic effects.
Poo JL; Jiménez W; María Muñoz R; Bosch-Marcé M; Bordas N; Morales-Ruiz M; Pérez M; Deulofeu R; Solé M; Arroyo V; Rodés J
Gastroenterology; 1999 Jan; 116(1):161-7. PubMed ID: 9869614
[TBL] [Abstract][Full Text] [Related]
2. Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats.
Cavasin MA; Semus H; Pitts K; Peng Y; Sandoval J; Chapo J; Plato CF
Can J Physiol Pharmacol; 2010 Jun; 88(6):636-43. PubMed ID: 20628429
[TBL] [Abstract][Full Text] [Related]
3. Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease.
Feng HQ; Weymouth ND; Rockey DC
Am J Physiol Gastrointest Liver Physiol; 2009 Jul; 297(1):G27-33. PubMed ID: 19299580
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-1 plays a major role in portal hypertension of biliary cirrhotic rats through endothelin receptor subtype B together with subtype A in vivo.
Kojima H; Sakurai S; Kuriyama S; Yoshiji H; Imazu H; Uemura M; Nakatani Y; Yamao J; Fukui H
J Hepatol; 2001 Jun; 34(6):805-11. PubMed ID: 11451162
[TBL] [Abstract][Full Text] [Related]
5. Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance.
Kojima H; Yamao J; Tsujimoto T; Uemura M; Takaya A; Fukui H
J Hepatol; 2000 Jan; 32(1):43-50. PubMed ID: 10673066
[TBL] [Abstract][Full Text] [Related]
6. Effect of endothelin A receptor antagonist on hepatic hemodynamics in cirrhotic rats. Implications for endothelin-1 in portal hypertension.
Takashimizu S; Kojima S; Nishizaki Y; Kagawa T; Shiraishi K; Mine T; Watanabe N
Tokai J Exp Clin Med; 2011 Jul; 36(2):37-43. PubMed ID: 21769771
[TBL] [Abstract][Full Text] [Related]
7. An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis.
Cho JJ; Hocher B; Herbst H; Jia JD; Ruehl M; Hahn EG; Riecken EO; Schuppan D
Gastroenterology; 2000 Jun; 118(6):1169-78. PubMed ID: 10833492
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria-targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats.
Vilaseca M; García-Calderó H; Lafoz E; Ruart M; López-Sanjurjo CI; Murphy MP; Deulofeu R; Bosch J; Hernández-Gea V; Gracia-Sancho J; García-Pagán JC
Liver Int; 2017 Jul; 37(7):1002-1012. PubMed ID: 28371136
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
[TBL] [Abstract][Full Text] [Related]
10. Diabetes enhances the intrahepatic vascular response to endothelin-1 in cirrhotic rats: association with the ETA receptor and pERK up-regulation.
Lee JY; Lee FY; Huo TI; Wang SS; Huang HC; Lin HC; Chuang CL; Lee SD
Liver Int; 2015 Mar; 35(3):704-12. PubMed ID: 24636620
[TBL] [Abstract][Full Text] [Related]
11. Effects of endothelin-1 on portal-systemic collaterals of common bile duct-ligated cirrhotic rats.
Chan CC; Wang SS; Lee FY; Chang FY; Lin HC; Hou MC; Huang HC; Lee SD
Eur J Clin Invest; 2004 Apr; 34(4):290-6. PubMed ID: 15086361
[TBL] [Abstract][Full Text] [Related]
12. Paracrine renal endothelin system in rats with liver cirrhosis.
Hocher B; Zart R; Diekmann F; Rohmeiss P; Distler A; Neumayer HH; Bauer C; Gross P
Br J Pharmacol; 1996 May; 118(2):220-7. PubMed ID: 8735618
[TBL] [Abstract][Full Text] [Related]
13. An endothelin receptor antagonist TAK-044 ameliorates carbon tetrachloride-induced acute liver injury and portal hypertension in rats.
Gandhi CR; Nemoto EM; Watkins SC; Subbotin VM
Liver; 1998 Feb; 18(1):39-48. PubMed ID: 9548266
[TBL] [Abstract][Full Text] [Related]
14. Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats.
Thirunavukkarasu C; Yang Y; Subbotin VM; Harvey SA; Fung J; Gandhi CR
Gut; 2004 Jul; 53(7):1010-9. PubMed ID: 15194653
[TBL] [Abstract][Full Text] [Related]
15. [Influence of platelet activating factor and its antagonist on portal hypertension associated with liver cirrhosis: an experiment with rats].
Wang CP; Han J; Ma XM; Dong K; Xiang Y; Su SH; Feng YY; Yang YP
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3337-41. PubMed ID: 16409839
[TBL] [Abstract][Full Text] [Related]
16. Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats.
Camara PR; Ferraz GJ; Franco-Penteado CF; Sbragia-Neto L; Meirelles LR; Teixeira SA; Muscara MN; Velloso LA; Antunes E; Ferraz JG
Eur J Pharmacol; 2008 Jul; 589(1-3):245-50. PubMed ID: 18555214
[TBL] [Abstract][Full Text] [Related]
17. Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats.
Sogni P; Moreau R; Gomola A; Gadano A; Cailmail S; Calmus Y; Clozel M; Lebrec D
Hepatology; 1998 Sep; 28(3):655-9. PubMed ID: 9731554
[TBL] [Abstract][Full Text] [Related]
18. Endothelin 1 does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites.
Leivas A; Jiménez W; Lamas S; Bosch-Marcé M; Oriola J; Clària J; Arroyo V; Rivera F; Rodés J
Gastroenterology; 1995 Jun; 108(6):1842-8. PubMed ID: 7768391
[TBL] [Abstract][Full Text] [Related]
19. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
García-Calderó H; Rodríguez-Vilarrupla A; Gracia-Sancho J; Diví M; Laviña B; Bosch J; García-Pagán JC
J Hepatol; 2011 Apr; 54(4):660-5. PubMed ID: 21159403
[TBL] [Abstract][Full Text] [Related]
20. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
